The CRISPR/Cas9 system was used to inserted behind the last exon a viral 2A oligopeptide that mediates ribosomal skipping and the light-activated ion channel channelrhodopsin-2 (ChR2) fused to an enhanced yellow fluorescent protein. (J:223507)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count